

Steve Harrision survived lung cancer | carboplatin | pleural fusion | pemetrexed | bronchoscopy
DESCRIPTION: When Steve Harrison experienced fatigue, back soreness and shoulder pain in 2024, he attributed it to his “getting old.” He was in his early fifties. But when he began to have difficulty breathing, he sought medical attention. Because Steve also had asthma, his doctor had COPD, she prescribed an inhaler. That did little to no good. He saw another doctor who ran a variety of tests, which found pleural fusion. After a bronchoscopy and a biopsy, he was diagn
11 hours ago13 min read


Marcel D’Allende survived Stage 4 Lung Cancer | carboplatin | pemetrexed | durvalumab | immunotherapy
DESCRIPTION Marcel D'Allende was in outstanding health, an avid hiker in the mountains overlooking her hometown of Cape Town, South Africa. However, in October 2021, she began to experience shortness of breath and extreme fatigue. That led to a diagnosis of Stage IV non-small cell adenocarcinoma, or lung cancer. Determined not to let cancer define her, she underwent a treatment regimen of radiotherapy, then chemotherapy with carboplatin and pemetrexed, and immunotherapy wi
Dec 11, 202512 min read


Jonathan Gegerson survived head and neck cancer | salivary duct carcinoma | taxol | herceptin
DESCRIPTION In 2019, Jonathan Gegerson sought medical attention went he felt a lump on the right side of his neck. After a couple of scans and a biopsy, he was diagnosed with salivary duct carcinoma, a rare form of head and neck cancer. Jonathan survived, but not before enduring 67 sessions of radiation, 12 cycles of chemotherapy (carboplatin, taxol, herceptin) and seven surgeries. He still undergoes a targeted therapy on a monthly basis, and the surgery has affected his s
Nov 4, 202511 min read


Thanks to chemotherapy plus taxotere and perjeta, Heidi Slansky survived Stage III breast cancer.
DESCRIPTION In her early forties, Heidi Slansky of Keller, Texas was in the best shape of her life. She was a fitness fanatic and loved...
May 16, 202218 min read
